Products and Services
Products and Services
Product Name
CAS Number
Specification
TP
DMF
Status
Cabozantinib
849217-68-1
In-house
Q4 2025
Dabrafenib mesylate
1195768-06-9
In-house
Q4 2025
Imatinib Mesylate
220127-57-1
EP, In-house
√
Lenvatinib Mesylate
857890-39-2
In-house
√
Olaparib
763113-22-0
In-house
√
Osimertinib mesylate
1421373-66-1
In-house
Q4 2025
Palbociclib
571190-30-2
In-house
√
Ruxolitinib (Phosphate)
941678-49-5&1092939-17-7
In-house
√
Trametinib dimethyl sulfoxide
1187431-43-1
In-house
Q4 2025
Tofacitinib Citrate
540737-29-9
In-house
√
Acalabrutinib
1420477-60-6
Q4 2025
Q2 2026
Alpelisib
1217486-61-7
Q4 2025
Q2 2026
Apalutamide
956104-40-8
Q3 2025
Q1 2026
Avapritinib
1703793-34-3
Q4 2025
Q2 2026
Capmatinib
1029712-80-8
Q4 2025
Q2 2026
Darolutamide
1297538-32-9
Q4 2025
Q2 2026
Deucravacitinib
1609392-27-9
Q4 2025
Q2 2026
Encorafenib
1269440-29-0
Q4 2025
Q2 2026
Fedratinib
936091-26-8
Q4 2025
Q2 2026
Gilteritinib
1254053-43-4
Q4 2025
Q2 2026
Email:
Company Address:
No.5, Donghai 4th Avenue, Zhejiang Chemical Materials Base Linhai Zone, Taizhou,Zhejiang,China
